Analgesics
Antiandrogens
Antihistamines
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Monoclonals
Mpro inhibitors
Naso/orophar..
Nigella Sativa
Nitazoxanide
PPIs
Quercetin
RdRp inhibitors
Thermotherapy
Vitamins
More

Other
Feedback
Home
 
next
study
previous
study
c19early.org COVID-19 treatment researchQuercetinQuercetin (more..)
Metformin Meta
Bromhexine Meta
Budesonide Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta PPIs Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta
Ivermectin Meta Thermotherapy Meta
Melatonin Meta

All Studies   Meta Analysis       

Secondary metabolites of Alternaria alternate appraisal of their SARS-CoV-2 inhibitory and anti-inflammatory potentials

Moharram et al., PLOS ONE, doi:10.1371/journal.pone.0313616
Jan 2025  
  Post
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
Quercetin for COVID-19
24th treatment shown to reduce risk in July 2021, now with p = 0.002 from 12 studies.
No treatment is 100% effective. Protocols combine treatments.
5,300+ studies for 115 treatments. c19early.org
In Silico and In Vitro study showing that compounds isolated from the fungus Alternaria alternate inhibit SARS-CoV-2 infection by blocking the ACE2-Spike protein interaction and reducing ACE2 expression and inflammatory cytokines. Quercetin was used as a positive control. Quercetin showed good binding affinity when docked into the binding interface between ACE-2 and the viral spike receptor binding domain (RBD), with nine possible conformers showing binding affinities ranging from -8.9 to -7.9 kcal/mol. For the In Vitro ACE-2:Spike RBD inhibition assay, quercetin demonstrated inhibitory activity with an IC50 value of 16.53 ± 0.44 μM.
Bioavailability. Quercetin has low bioavailability and studies typically use advanced formulations to improve bioavailability which may be required to reach therapeutic concentrations.
75 preclinical studies support the efficacy of quercetin for COVID-19:
In Silico studies predict inhibition of SARS-CoV-2, or minimization of side effects, with quercetin or metabolites via binding to the spikeA,3,4,10,11,23,25,26,28,31,39,40,42,43,63, MproB,3,4,8,10,12,14,16,18,19,21,24,25,28,31,35,37-39,43-46, RNA-dependent RNA polymeraseC,2-4,10,33, PLproD,4,38,46, ACE2E,23,24,28,29,38,42, TMPRSS2F,23, nucleocapsidG,4, helicaseH,4,30,35, endoribonucleaseI,40, NSP16/10J,7, cathepsin LK,27, Wnt-3L,23, FZDM,23, LRP6N,23, ezrinO,41, ADRPP,39, NRP1Q,42, EP300R,17, PTGS2S,24, HSP90AA1T,17,24, matrix metalloproteinase 9U,32, IL-6V,22,36, IL-10W,22, VEGFAX,36, and RELAY,36 proteins, and inhibition of spike-ACE2 interactionZ,1. In Vitro studies demonstrate inhibition of the MproB,16,47,52,60 protein, and inhibition of spike-ACE2 interactionZ,48. In Vitro studies demonstrate efficacy in Calu-3AA,51, A549AB,22, HEK293-ACE2+AC,59, Huh-7AD,26, Caco-2AE,50, Vero E6AF,20,43,50, mTECAG,53, RAW264.7AH,53, and HLMECAI,1 cells. Animal studies demonstrate efficacy in K18-hACE2 miceAJ,56, db/db miceAK,53,62, BALB/c miceAL,61, and rats20. Quercetin reduced proinflammatory cytokines and protected lung and kidney tissue against LPS-induced damage in mice61, inhibits LPS-induced cytokine storm by modulating key inflammatory and antioxidant pathways in macrophages6, and inhibits SARS-CoV-2 ORF3a ion channel activity, which contributes to viral pathogenicity and cytotoxicity55.
a. The trimeric spike (S) protein is a glycoprotein that mediates viral entry by binding to the host ACE2 receptor, is critical for SARS-CoV-2's ability to infect host cells, and is a target of neutralizing antibodies. Inhibition of the spike protein prevents viral attachment, halting infection at the earliest stage.
b. The main protease or Mpro, also known as 3CLpro or nsp5, is a cysteine protease that cleaves viral polyproteins into functional units needed for replication. Inhibiting Mpro disrupts the SARS-CoV-2 lifecycle within the host cell, preventing the creation of new copies.
c. RNA-dependent RNA polymerase (RdRp), also called nsp12, is the core enzyme of the viral replicase-transcriptase complex that copies the positive-sense viral RNA genome into negative-sense templates for progeny RNA synthesis. Inhibiting RdRp blocks viral genome replication and transcription.
d. The papain-like protease (PLpro) has multiple functions including cleaving viral polyproteins and suppressing the host immune response by deubiquitination and deISGylation of host proteins. Inhibiting PLpro may block viral replication and help restore normal immune responses.
e. The angiotensin converting enzyme 2 (ACE2) protein is a host cell transmembrane protein that serves as the cellular receptor for the SARS-CoV-2 spike protein. ACE2 is expressed on many cell types, including epithelial cells in the lungs, and allows the virus to enter and infect host cells. Inhibition may affect ACE2's physiological function in blood pressure control.
f. Transmembrane protease serine 2 (TMPRSS2) is a host cell protease that primes the spike protein, facilitating cellular entry. TMPRSS2 activity helps enable cleavage of the spike protein required for membrane fusion and virus entry. Inhibition may especially protect respiratory epithelial cells, buy may have physiological effects.
g. The nucleocapsid (N) protein binds and encapsulates the viral genome by coating the viral RNA. N enables formation and release of infectious virions and plays additional roles in viral replication and pathogenesis. N is also an immunodominant antigen used in diagnostic assays.
h. The helicase, or nsp13, protein unwinds the double-stranded viral RNA, a crucial step in replication and transcription. Inhibition may prevent viral genome replication and the creation of new virus components.
i. The endoribonuclease, also known as NendoU or nsp15, cleaves specific sequences in viral RNA which may help the virus evade detection by the host immune system. Inhibition may hinder the virus's ability to mask itself from the immune system, facilitating a stronger immune response.
j. The NSP16/10 complex consists of non-structural proteins 16 and 10, forming a 2'-O-methyltransferase that modifies the viral RNA cap structure. This modification helps the virus evade host immune detection by mimicking host mRNA, making NSP16/10 a promising antiviral target.
k. Cathepsin L is a host lysosomal cysteine protease that can prime the spike protein through an alternative pathway when TMPRSS2 is unavailable. Dual targeting of cathepsin L and TMPRSS2 may maximize disruption of alternative pathways for virus entry.
l. Wingless-related integration site (Wnt) ligand 3 is a host signaling molecule that activates the Wnt signaling pathway, which is important in development, cell growth, and tissue repair. Some studies suggest that SARS-CoV-2 infection may interfere with the Wnt signaling pathway, and that Wnt3a is involved in SARS-CoV-2 entry.
m. The frizzled (FZD) receptor is a host transmembrane receptor that binds Wnt ligands, initiating the Wnt signaling cascade. FZD serves as a co-receptor, along with ACE2, in some proposed mechanisms of SARS-CoV-2 infection. The virus may take advantage of this pathway as an alternative entry route.
n. Low-density lipoprotein receptor-related protein 6 is a cell surface co-receptor essential for Wnt signaling. LRP6 acts in tandem with FZD for signal transduction and has been discussed as a potential co-receptor for SARS-CoV-2 entry.
o. The ezrin protein links the cell membrane to the cytoskeleton (the cell's internal support structure) and plays a role in cell shape, movement, adhesion, and signaling. Drugs that occupy the same spot on ezrin where the viral spike protein would bind may hindering viral attachment, and drug binding could further stabilize ezrin, strengthening its potential natural capacity to impede viral fusion and entry.
p. The Adipocyte Differentiation-Related Protein (ADRP, also known as Perilipin 2 or PLIN2) is a lipid droplet protein regulating the storage and breakdown of fats in cells. SARS-CoV-2 may hijack the lipid handling machinery of host cells and ADRP may play a role in this process. Disrupting ADRP's interaction with the virus may hinder the virus's ability to use lipids for replication and assembly.
q. Neuropilin-1 (NRP1) is a cell surface receptor with roles in blood vessel development, nerve cell guidance, and immune responses. NRP1 may function as a co-receptor for SARS-CoV-2, facilitating viral entry into cells. Blocking NRP1 may disrupt an alternative route of viral entry.
r. EP300 (E1A Binding Protein P300) is a transcriptional coactivator involved in several cellular processes, including growth, differentiation, and apoptosis, through its acetyltransferase activity that modifies histones and non-histone proteins. EP300 facilitates viral entry into cells and upregulates inflammatory cytokine production.
s. Prostaglandin G/H synthase 2 (PTGS2, also known as COX-2) is an enzyme crucial for the production of inflammatory molecules called prostaglandins. PTGS2 plays a role in the inflammatory response that can become severe in COVID-19 and inhibitors (like some NSAIDs) may have benefits in dampening harmful inflammation, but note that prostaglandins have diverse physiological functions.
t. Heat Shock Protein 90 Alpha Family Class A Member 1 (HSP90AA1) is a chaperone protein that helps other proteins fold correctly and maintains their stability. HSP90AA1 plays roles in cell signaling, survival, and immune responses. HSP90AA1 may interact with numerous viral proteins, but note that it has diverse physiological functions.
u. Matrix metalloproteinase 9 (MMP9), also called gelatinase B, is a zinc-dependent enzyme that breaks down collagen and other components of the extracellular matrix. MMP9 levels increase in severe COVID-19. Overactive MMP9 can damage lung tissue and worsen inflammation. Inhibition of MMP9 may prevent excessive tissue damage and help regulate the inflammatory response.
v. The interleukin-6 (IL-6) pro-inflammatory cytokine (signaling molecule) has a complex role in the immune response and may trigger and perpetuate inflammation. Elevated IL-6 levels are associated with severe COVID-19 cases and cytokine storm. Anti-IL-6 therapies may be beneficial in reducing excessive inflammation in severe COVID-19 cases.
w. The interleukin-10 (IL-10) anti-inflammatory cytokine helps regulate and dampen immune responses, preventing excessive inflammation. IL-10 levels can also be elevated in severe COVID-19. IL-10 could either help control harmful inflammation or potentially contribute to immune suppression.
x. Vascular Endothelial Growth Factor A (VEGFA) promotes the growth of new blood vessels (angiogenesis) and has roles in inflammation and immune responses. VEGFA may contribute to blood vessel leakiness and excessive inflammation associated with severe COVID-19.
y. RELA is a transcription factor subunit of NF-kB and is a key regulator of inflammation, driving pro-inflammatory gene expression. SARS-CoV-2 may hijack and modulate NF-kB pathways.
z. The interaction between the SARS-CoV-2 spike protein and the human ACE2 receptor is a primary method of viral entry, inhibiting this interaction can prevent the virus from attaching to and entering host cells, halting infection at an early stage.
aa. Calu-3 is a human lung adenocarcinoma cell line with moderate ACE2 and TMPRSS2 expression and SARS-CoV-2 susceptibility. It provides a model of the human respiratory epithelium, but many not be ideal for modeling early stages of infection due to the moderate expression levels of ACE2 and TMPRSS2.
ab. A549 is a human lung carcinoma cell line with low ACE2 expression and SARS-CoV-2 susceptibility. Viral entry/replication can be studied but the cells may not replicate all aspects of lung infection.
ac. HEK293-ACE2+ is a human embryonic kidney cell line engineered for high ACE2 expression and SARS-CoV-2 susceptibility.
ad. Huh-7 cells were derived from a liver tumor (hepatoma).
ae. Caco-2 cells come from a colorectal adenocarcinoma (cancer). They are valued for their ability to form a polarized cell layer with properties similar to the intestinal lining.
af. Vero E6 is an African green monkey kidney cell line with low/no ACE2 expression and high SARS-CoV-2 susceptibility. The cell line is easy to maintain and supports robust viral replication, however the monkey origin may not accurately represent human responses.
ag. mTEC is a mouse tubular epithelial cell line.
ah. RAW264.7 is a mouse macrophage cell line.
ai. HLMEC (Human Lung Microvascular Endothelial Cells) are primary endothelial cells derived from the lung microvasculature. They are used to study endothelial function, inflammation, and viral interactions, particularly in the context of lung infections such as SARS-CoV-2. HLMEC express ACE2 and are susceptible to SARS-CoV-2 infection, making them a relevant model for studying viral entry and endothelial responses in the lung.
aj. A mouse model expressing the human ACE2 receptor under the control of the K18 promoter.
ak. A mouse model of obesity and severe insulin resistance leading to type 2 diabetes due to a mutation in the leptin receptor gene that impairs satiety signaling.
al. A mouse model commonly used in infectious disease and cancer research due to higher immune response and susceptibility to infection.
Moharram et al., 24 Jan 2025, peer-reviewed, 10 authors. Contact: kueihunglai@tmu.edu.tw.
In Vitro studies are an important part of preclinical research, however results may be very different in vivo.
This PaperQuercetinAll
Secondary metabolites of Alternaria alternate appraisal of their SARS-CoV-2 inhibitory and anti-inflammatory potentials
Fatma A Moharram, Reham R Ibrahim, Shahenda Mahgoub, Mohamed S Abdel-Aziz, Ahmed M Said, Hui-Chi Huang, Lo-Yun Chen, Kuei-Hung Lai, Nashwa Hashad, Mohamed S Mady
PLOS ONE, doi:10.1371/journal.pone.0313616
This study identifies the secondary metabolites from Alternaria alternate and evaluates their ACE-2: Spike RBD (SARS-CoV-2) inhibitory activity confirmed via immunoblotting in human lung microvascular endothelial cells. In addition, their in vitro anti-inflammatory potential was assessed using a cell-based assay in LPS-treated RAW 264.7 macrophage cells. Two novel compounds, altenuline (1), phthalic acid bis (7'/7'' pentyloxy) isohexyl ester (2), along with 1-deoxyrubralactone (3) alternariol-5-O-methyl ether (4) and alternariol (5) were identified. Molecular docking and in vitro studies showed that compounds 2 and 4 were promising to counteract SARS-CoV-2 attachment to human ACE-2. Thus, they are considered promising natural anti-viral agents. SwissADME in silico analysis was conducted to predict the drug-like potential. Immunoblotting analysis confirmed that the tested compounds (1-4) demonstrated downregulation of ACE-2 expression in the endothelial cells from the lungs with variable degrees. Furthermore, the tested compounds (1-4) showed promising antiinflammatory activities through TNF-α: TNFR2 inhibitory activity and their inhibitory effect on the proinflammatory cytokines (TNF-α and IL-6) in LPS-stimulated monocytes. In conclusion, our study, for the first time, provides beneficial experimental confirmation for the efficiency of the A. alternate secondary metabolites for the treatment of COVID-19 as they hinder SARS-CoV-2 infection and lower inflammatory responses initiated by SARS-CoV-2. A. alternate and its metabolites are considered in developing preventative and therapeutic tactics for COVID-19.
Supporting information S1
References
Abd, Studying of antibacterial effect for leaves extract of Callistemon viminalis in vitro and vivo (urinary system) for rabbits, JOK
Abdelhady, Youns, In-vitro evaluation of the antidiabetic activity of bottle brush plants, RRBS
Abraham, Murtola, Schulz, Smith, Hess, GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers, SoftwareX, doi:10.1016/j.softx.2015.06.001
Ahmad, Athar, Phytochemistry and Pharmacology of Callistemon viminali (Myrtaceae): A Review, Nat Prod J, doi:10.2174/2210315507666161216100323
Ahmad, Evaluating anti-oxidant potential of Callistemon viminalis leaves extracts and their compounds in STAT 3 pathway in liver cancer, Annals of Oncology, doi:10.1093/annonc/mdx652.013
Ahmed, Phytochemical and Cytotoxicity Studies of Callistemon viminalis Leaves Extract Growing in Egypt, Curr Pharm Biotechnol, doi:10.2174/1389201020666191107110341
Alam, Rashid, Sarker, Emon, Arman et al., Antidiarrheal, antimicrobial and antioxidant potentials of methanol extract of Colocasia gigantea Hook. f. leaves: evidenced from in vivo and in vitro studies along with computer-aided approaches, BMC Complementary Medicine and Therapies, doi:10.1186/s12906-021-03290-6
Bahbah, Negida, Nabet, Purposing Saikosaponins for the treatment of COVID-19, Med Hypotheses, doi:10.1016/j.mehy.2020.109782
Benigni, Cassis, Remuzzi, Angiotensin II revisited: new roles in inflammation, immunology and aging, EMBO Mol Med, doi:10.1002/emmm.201000080
Bhagat, Sangral, Pandita, Vironica, Gupta et al., Pleiotropic Chemodiversity in Extracts and Essential Oil of Melaleuca viminalis and Melaleuca armillaris of Myrtaceae Family, JERP, doi:10.14218/jerp.2016.00036
Biancatelli, Berrill, Catravas, Marik, Quercetin and Vitamin C: An Experimental, Synergistic Therapy for the Prevention and Treatment of SARS-CoV-2 Related Disease, COVID, doi:10.3389/fimmu.2020.01451
Bradford, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding, Anal Biochem, doi:10.1016/0003-2697%2876%2990527-3
Brogi, Quimque, Notarte, Africa, Hernandez et al., Virtual Combinatorial Library Screening of Quinadoline B Derivatives against SARS-CoV-2 RNA-Dependent RNA Polymerase, Computation
Chen, Boorla, Banerjee, Chowdhury, Cavener et al., Computational prediction of the effect of amino acid changes on the binding affinity between SARS-CoV-2 spike RBD and human ACE2, Proceedings of the National Academy of Sciences, doi:10.1073/pnas.2106480118
Chen, Jiang, Xia, Liu, Yu et al., Individual variation of the SARS-CoV-2 receptor ACE2 gene expression and regulation, Aging Cell, doi:10.1111/acel.13168
Chen, Wang, Yu, Howard, French et al., The Spatial and Cell-Type Distribution of SARS-CoV-2 Receptor ACE2 in the Human and Mouse Brains, Front Neurol, doi:10.3389/fneur.2020.573095
Chen, Wu, Cao, Wang, Zhang et al., Clinical and immunological features of severe and moderate coronavirus disease 2019, J Clin Invest, doi:10.1172/JCI137244
Chung, Stress Response and Pathogenicity of the Necrotrophic Fungal Pathogen Alternaria alternata, Scientifica, doi:10.6064/2012/635431
Correia, Fernandes, Alves, Carrondo, Roldão, Improving Influenza HA-Vlps Production in Insect High Five Cells via Adaptive Laboratory Evolution, Vaccines, doi:10.3390/vaccines8040589
Crackower, Sarao, Oudit, Yagil, Kozieradzki et al., Angiotensin-converting enzyme 2 is an essential regulator of heart function, Nature, doi:10.1038/nature00786
Dalan, Bornstein, El-Armouche, Rodionov, Markov et al., The ACE-2 in COVID-19: Foe or Friend?, Horm Metab Res, doi:10.1055/a-1155-0501
Dandona, Dhindsa, Ghanim, Chaudhuri, Angiotensin II and inflammation: the effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockade, J Hum Hypertens, doi:10.1038/sj.jhh.1002101
Datta, Liu, Fischer, Rappaport, Qin, SARS-CoV-2 pandemic and research gaps: Understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapy, Theranostics, doi:10.7150/thno.48076
Dela Cruz, Notarte, Apurillo, Tarman, Bungihan, Chapter 4-Biomining fungal endophytes from tropical plants and seaweeds for drug discovery
Ebrahimi, Ansari, Moghaddam, Ebrahimi, Salehi et al., In silico investigation on the inhibitory effect of fungal secondary metabolites on RNA dependent RNA polymerase of SARS-CoV-II: A docking and molecular dynamic simulation study, Computers in Biology and Medicine, doi:10.1016/j.compbiomed.2021.104613
Eram, Arthikala, Melappa, Santoyo, Alternaria species: endophytic fungi as alternative sources of bioactive compounds, Italian Journal of Mycology, doi:10.6092/issn.2531-7342/8468
Fayek, Ebrahim, Elsayed, Abelaziz, Kariuki et al., Anti-prostate cancer metabolites from the soil-derived Aspergillus neoniveus, Front Pharmacol, doi:10.3389/fphar.2022.1006062
Fayek, Ebrahim, Ms, Taha, Moharram, Bioactive metabolites identified from Aspergillus terreus derived from soil, AMB Express, doi:10.1186/s13568-023-01612-0
Frediansyah, Sofyantoro, Alhumaid, Mutair, Albayat et al., Microbial Natural Products with Antiviral Activities, Including Anti-SARS-CoV-2: A Review. LID-LID-4305, Molecules
Giovinazzo, Gerardi, Uberti-Foppa, Lopalco, Can Natural Polyphenols Help in Reducing Cytokine Storm in COVID-19 Patients?, Molecules, doi:10.3390/molecules25245888
Gohar, Maatooq, Gadara, Aboelmaaty, One new pyrroline compound from Callistemon viminalis (Sol. Ex Gaertner) G.Don Ex Loudon, Nat Prod Res, doi:10.1080/14786419.2012.718771
Hakim, SARS-CoV-2, Covid-19, and the debunking of conspiracy theories, Reviews in Medical Virology, doi:10.1002/rmv.2222
Hasan, Mamun, Belal, Rahman, Ali et al., A report on antioxidant and antibacterial properties of Callistemon viminalis leaf, International Journal of Pharmaceutical Science and Research
Hashad, Mady, Aziz, Moharram, Review: Bioactive metabolites and host-specific toxins from endophytic Fungi, Alternaria alternate, Vietnam Journal of Chemistry, doi:10.1002/vjch.202100099
Hassan, Novel natural products from endophytic fungi of Egyptian medicinal plants-chemical and biological characterization
Hawas, El-Desouky, El-Kassem, Elkhateeb, Alternariol derivatives from Alternaria alternata, an endophytic fungus residing in red sea soft coral, inhibit HCV NS3/4A protease, Applied Biochemistry and Microbiology, doi:10.1134/S0003683815050099
Hirano, Murakami, COVID-19: A New Virus, but a Familiar Receptor and Cytokine Release Syndrome, Immunity, doi:10.1016/j.immuni.2020.04.003
Hoffmann, Kleine-Weber, Schroeder, Kruger, Herrler et al., SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor, Cell, doi:10.1016/j.cell.2020.02.052
Huang, Tao, Liu, Cai, Huang et al., Current prevention of COVID-19: natural products and herbal medicine, Frontiers in Pharmacology, doi:10.3389/fphar.2020.588508
Huang, Yang, Xu, -F, Xu et al., Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19, Acta Pharmacologica Sinica, doi:10.1038/s41401-020-0485-4
Iacob, Iacob, SARS-CoV-2 Treatment Approaches: Numerous Options, No Certainty for a Versatile Virus, Front Pharmacol, doi:10.3389/fphar.2020.01224
Idris, Idris, Antibacterial activity of endophytic fungi extracts from the medicinal plant Kigelia africana, Egypt Acad J Biol Sci
Innis, Gelfand, Sninsky, White, PCR protocols: a guide to methods and applications
Islam, Sarkar, El-Kersh, Jamaddar, Uddin et al., Natural products and their derivatives against coronavirus: A review of the non-clinical and pre-clinical data, PHYTOTHER RES, doi:10.1002/ptr.6700
Jani, Koulgi, Uppuladinne, Sonavane, Computational Drug Repurposing Studies on the ACE2-Spike (RBD) Interface of SARS-CoV-22020
Kamble, Gacche, Evaluation of anti-breast cancer, anti-angiogenic and antioxidant properties of selected medicinal plants, EuJIM, doi:10.1016/j.eujim.2018.11.006
Kumar, Vani, Wang, Chen, Chen et al., Geranium and lemon essential oils and their active compounds downregulate angiotensin-converting enzyme 2 (ACE2), a SARS-CoV-2 spike receptor-binding domain, in epithelial cells, Plants, doi:10.3390/plants9060770
Kumari, Kumar, g_mmpbsa-A GROMACS Tool for High-Throughput MM-PBSA Calculations, Journal of Chemical Information and Modeling, doi:10.1021/ci500020m
Lan, Ge, Yu, Shan, Zhou et al., Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor, Nature, doi:10.1038/s41586-020-2180-5
Lee, Lee, Kim, Chang, Chung et al., The PreADME Approach: Web-based program for rapid prediction of physico-chemical, drug absorption and drug-like properties. euro QSAR 2002-Designing, Drugs and Crop Protectants: Processes Problems and Solutions
Liu, Chen, Liu, Li, Wu et al., Callviminols A-E, new terpenoid-conjugated phloroglucinols from the leaves of Callistemon viminalis, Fitoterapia, doi:10.1016/j.fitote.2016.10.007
Liu, Raghuvanshi, Ceylan, Bolling, Quercetin and Its Metabolites Inhibit Recombinant Human Angiotensin-Converting Enzyme 2 (ACE2) Activity, Journal of Agricultural and Food Chemistry, doi:10.1021/acs.jafc.0c05064
Lou, Fu, Peng, Zhou, Metabolites from Alternaria fungi and their bioactivities, Molecules, doi:10.3390/molecules18055891
Mahgoub, Fatahala, Sayed, Atya, El-Shehry et al., Novel hit of DPP-4Is as promising antihyperglycemic agents with dual antioxidant/anti-inflammatory effects for type 2 diabetes with/without COVID-19, Bioorganic Chemistry, doi:10.1016/j.bioorg.2022.106092
Mahgoub, Hashad, Ali, Ibrahim, Said et al., Polyphenolic Profile of Callistemon viminalis Aerial Parts: Antioxidant, Anticancer and In Silico 5-LOX Inhibitory Evaluations, Molecules, doi:10.3390/molecules26092481
Mangalmurti, Hunter, Cytokine Storms: Understanding COVID-19, Immunity, doi:10.1016/j.immuni.2020.06.017
Manjunath, Thimmulappa, Antiviral, immunomodulatory, and anticoagulant effects of quercetin and its derivatives: Potential role in prevention and management of COVID-19, Journal of Pharmaceutical Analysis, doi:10.1016/j.jpha.2021.09.009
Mei, Flinn, The use of beneficial microbial endophytes for plant biomass and stress tolerance improvement, Recent Pat Biotechnol, doi:10.2174/187220810790069523
Montemurro, Visconti, Alternaria metabolites-chemical and biological data. Alternaria: biology, plant diseases, and metabolites/editors, J Chelkowski and A Visconti
Mosmann, Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays, Journal of immunological methods, doi:10.1016/0022-1759%2883%2990303-4
Muchtaridi, Fauzi, Ikram, Gazzali, Wahab, Natural Flavonoids as Potential Angiotensin-Converting Enzyme 2 Inhibitors for Anti-SARS-CoV-2, Molecules, doi:10.3390/molecules25173980
Muniandy, Gothai, Badran, Kumar, Esa et al., Suppression of Proinflammatory Cytokines and Mediators in LPS-Induced RAW 264.7 Macrophages by Stem Extract of Alternanthera sessilis via the Inhibition of the NF-κB Pathway, J Immun Res, doi:10.1155/2018/3430684
Naganuma, Nishida, Kuramochi, Sugawara, Yoshida et al., 1-deoxyrubralactone, a novel specific inhibitor of families X and Y of eukaryotic DNA polymerases from a fungal strain derived from sea algae, Bioorg Med Chem, doi:10.1016/j.bmc.2007.12.044
Noor, Almasri, Bagalagel, Abdallah, Mohamed et al., Naturally Occurring Isocoumarins Derivatives from Endophytic Fungi: Sources, Isolation, Structural Characterization, Biosynthesis, and Biological Activities, Molecules, doi:10.3390/molecules25020395
Notarte, Quimque, Macaranas, Khan, Pastrana et al., Attenuation of Lipopolysaccharide-Induced Inflammatory Responses through Inhibition of the NF-κB Pathway and the Increased NRF2 Level by a Flavonol-Enriched n-Butanol Fraction from Uvaria alba, ACS Omega, doi:10.1021/acsomega.2c06451
Ocaranza, Godoy, Jalil, Varas, Collantes et al., Enalapril Attenuates Downregulation of Angiotensin-Converting Enzyme 2 in the Late Phase of Ventricular Dysfunction in Myocardial Infarcted Rat, Hypertension, doi:10.1161/01.HYP.0000237862.94083.45
Ortı, -Casañ, Wu, Naude, De Deyn et al., Targeting TNFR2 as a novel therapeutic strategy for Alzheimer's disease, Front Neurosci, doi:10.3389/fnins.2019.00049
Othman, Bouslama, Brandenburg, Da Rocha, Hamdi et al., Interaction of the spike protein RBD from SARS-CoV-2 with ACE2: Similarity with SARS-CoV, hot-spot analysis and effect of the receptor polymorphism, Biochem Biophys Res Commun, doi:10.1016/j.bbrc.2020.05.028
Park, Jeon, Kim, Jeon, Jeong et al., Draft genome sequence of Alternaria alternata JS-1623, a fungal endophyte of Abies koreana, Mycobiology, doi:10.1080/12298093.2020.1756134
Pedersen, Ho, SARS-CoV-2: a storm is raging, J Clin Invest, doi:10.1172/JCI137647
Peiris, St Fau-Poon, Ll Fau-Guan, Guan, Fau-Yam et al., Coronavirus as a possible cause of severe acute respiratory syndrome, Lancet, doi:10.1016/s0140-6736%2803%2913077-2
Petrini, Taxonomy of endophytic fungi of aerial plant tissues
Pilapil, Notarte, Yeung, The dominance of co-circulating SARS-CoV-2 variants in wastewater, International Journal of Hygiene and Environmental Health, doi:10.1016/j.ijheh.2023.114224
Quimque Tristan, Israel, Amor, Harvey, De et al., Polyphenolic Natural Products Active In Silico Against SARS-CoV-2 Spike Receptor Binding Domains and Non-structural Proteins-A Review, Combinatorial Chemistry & High Throughput Screening, doi:10.2174/1386207325666210917113207
Raihan, Rabbee, Roy, Choudhury, Baek et al., Microbial Metabolites: The Emerging Hotspot of Antiviral Compounds as Potential Candidates to Avert Viral Pandemic Alike COVID-19, Front Mol Biosci, doi:10.3389/fmolb.2021.732256
Robinson, Richards, Tanner, Feldmann, Accumulating evidence suggests anti-TNF therapy needs to be given trial priority in COVID-19 treatment, The Lancet Rheumatology, doi:10.1016/S2665-9913%2820%2930309-X
Saeedi-Boroujeni, Mr, Anti-inflammatory potential of Quercetin in COVID-19 treatment, J Inflamm (Lond), doi:10.1186/s12950-021-00268-6
Salem, Ali, El-Shanhorey, Megeed, Evaluation of extracts and essential oil from Callistemon viminalis leaves: antibacterial and antioxidant activities, total phenolic and flavonoid contents, Asian Pac J Trop Med, doi:10.1016/S1995-7645%2813%2960139-X
Salem, El-Hefny, Nasser, Ali, El-Shanhorey et al., Medicinal and biological values of Callistemon viminalis extracts: History, current situation and prospects, Asian Pac J Trop Med, doi:10.1016/j.apjtm.2017.03.015
Salesi, Shojaie, Farajzadegan, Salesi, Mohammadi, TNF-α Blockers Showed Prophylactic Effects in Preventing COVID-19 in Patients with Rheumatoid Arthritis and Seronegative Spondyloarthropathies: A Case-Control Study, doi:10.1007/s40744-021-00342-8
Santos, Sampaio, Alzamora, Motta-Santos, Alenina et al., The ACE2/ Angiotensin-(1-7)/MAS Axis of the Renin-Angiotensin System: Focus on Angiotensin-(1-7), Physiological Reviews, doi:10.1152/physrev.00023.2016
Schulz, Wanke, Draeger, Aust, Endophytes from herbaceous plants and shrubs: effectiveness of surface sterilization methods, Mycol Res, doi:10.1016/S0953-7562(09)80215-3
Scialo, Amato, Pastore, Matera, Cazzola, ACE2: The Major Cell Entry Receptor for SARS-CoV-2, Lung, doi:10.1007/s00408-020-00408-4
Shang, Ye, Shi, Wan, Luo et al., Structural basis of receptor recognition by SARS-CoV-2, Nature, doi:10.1038/s41586-020-2179-y
Shareef, Naeem, Zaheer, Comparative Analgesic Activity of Selected Medicinal Plants from Pakistan, Proceedings of the Pakistan Academy of Sciences: B Life and Environmental Sciences
Sharma, Stevens, Obukhov, Grant, Oudit et al., ACE2 (Angiotensin-Converting Enzyme 2) in Cardiopulmonary Diseases: Ramifications for the Control of SARS-CoV-2, Hypertension, doi:10.1161/HYPERTENSIONAHA.120.15595
Souza, Mitho ¨fer, Daolio, Schneider, Rodrigues-Filho, Identification of Alternaria alternata mycotoxins by LC-SPE-NMR and their cytotoxic effects to soybean (Glycine max) cell suspension culture, Molecules, doi:10.3390/molecules18032528
Spina, Ropars, Bouazzi, Dadi, Lemiere et al., Screening of Anti-Inflammatory Activity and Metabolomics Analysis of Endophytic Fungal Extracts; Identification and Characterization of Perylenequinones and Terpenoids from the Interesting Active Alternaria Endophyte, Molecules, doi:10.3390/molecules28186531
Sternberg, Naujokat, Structural features of coronavirus SARS-CoV-2 spike protein: Targets for vaccination, Life Sciences, doi:10.1016/j.lfs.2020.118056
Tang, Liu, Zhang, Xu, Wen, Cytokine Storm in COVID-19: The Current Evidence and Treatment Strategies, Front Immunol, doi:10.3389/fimmu.2020.01708
Tiwari, Jadon, Nigam, Evaluation of antioxidant and antibacterial activities of methanolic leaf extract of Calistemon viminalis, JPSBM
Trott, Olson, AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading, Journal of Computational Chemistry, doi:10.1002/jcc.21334
Vanamee, Faustman, TNFR2: A Novel Target for Cancer Immunotherapy, Trends Mol Med, doi:10.1016/j.molmed.2017.09.007
Wang, Zhang, Wu, Niu, Song et al., Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2, Cell, doi:10.1016/j.cell.2020.03.045
Widagdo, Begeman, Schipper, Prv, Cunningham et al., Tissue distribution of the MERS-coronavirus receptor in bats, Scientific Reports, doi:10.1038/s41598-017-01290-6
Wu, Li, Tang, Ke, Zhu et al., Callistemonols A and B, Potent Antimicrobial Acylphloroglucinol Derivatives with Unusual Carbon Skeletons from Callistemon viminalis, J Nat Prod, doi:10.1021/acs.jnatprod.9b00064
Wu, Zhang, Wang, Liu, Yang et al., Acylphloroglucinols from the fruits of Callistemon viminalis, Phytochem Lett, doi:10.1016/j.phytol.2017.04.014
Xia, Zhu, Liu, Lan, Xu et al., Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein, Cell Mol Immunol, doi:10.1038/s41423-020-0374-2
Xu, Lou, Liu, Pang, Tien et al., Crystal structure of severe acute respiratory syndrome coronavirus spike protein fusion core, J Biol Chem, doi:10.1074/jbc.M408782200
Yan, Zhang, Li, Xia, Guo et al., Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2, Science, doi:10.1126/science.abb2762
Yang, Petitjean, Koehler, Zhang, Dumitru et al., Molecular interaction and inhibition of SARS-CoV-2 binding to the ACE2 receptor, Nature Communications, doi:10.1038/s41467-020-18319-6
Zhang, Liu, Wang, Yang, Li et al., SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19, J Hematol Oncol, doi:10.1186/s13045-020-00954-7
Zhou, Yang, Wang, Hu, Zhang et al., A pneumonia outbreak associated with a new coronavirus of probable bat origin, Nature, doi:10.1038/s41586-020-2012-7
Zipeto, Jdf, Argañaraz, Argañaraz, ACE2/ADAM17/TMPRSS2 Interplay May Be the Main Risk Factor for COVID-19, Front Immunol, doi:10.3389/fimmu.2020.576745
DOI record: { "DOI": "10.1371/journal.pone.0313616", "ISSN": [ "1932-6203" ], "URL": "http://dx.doi.org/10.1371/journal.pone.0313616", "abstract": "<jats:p>This study identifies the secondary metabolites from <jats:italic>Alternaria alternate</jats:italic> and evaluates their ACE-2: Spike RBD (SARS-CoV-2) inhibitory activity confirmed <jats:italic>via</jats:italic> immunoblotting in human lung microvascular endothelial cells. In addition, their <jats:italic>in vitro</jats:italic> anti-inflammatory potential was assessed using a cell-based assay in LPS-treated RAW 264.7 macrophage cells. Two novel compounds, altenuline (<jats:bold>1</jats:bold>), phthalic acid bis (7’/7’’ pentyloxy) isohexyl ester (<jats:bold>2</jats:bold>), along with 1-deoxyrubralactone (<jats:bold>3</jats:bold>) alternariol-5-<jats:italic>O</jats:italic>-methyl ether (<jats:bold>4</jats:bold>) and alternariol (<jats:bold>5</jats:bold>) were identified. Molecular docking and <jats:italic>in vitro</jats:italic> studies showed that compounds <jats:bold>2</jats:bold> and <jats:bold>4</jats:bold> were promising to counteract SARS-CoV-2 attachment to human ACE-2. Thus, they are considered promising natural anti-viral agents. SwissADME in silico analysis was conducted to predict the drug-like potential. Immunoblotting analysis confirmed that the tested compounds (<jats:bold>1–4</jats:bold>) demonstrated downregulation of ACE-2 expression in the endothelial cells from the lungs with variable degrees. Furthermore, the tested compounds (<jats:bold>1–4</jats:bold>) showed promising anti-inflammatory activities through TNF-α: TNFR2 inhibitory activity and their inhibitory effect on the proinflammatory cytokines (TNF-α and IL-6) in LPS-stimulated monocytes. In conclusion, our study, for the first time, provides beneficial experimental confirmation for the efficiency of the <jats:italic>A</jats:italic>. <jats:italic>alternate</jats:italic> secondary metabolites for the treatment of COVID-19 as they hinder SARS-CoV-2 infection and lower inflammatory responses initiated by SARS-CoV-2. <jats:italic>A</jats:italic>. <jats:italic>alternate</jats:italic> and its metabolites are considered in developing preventative and therapeutic tactics for COVID-19.</jats:p>", "author": [ { "affiliation": [], "family": "Moharram", "given": "Fatma A.", "sequence": "first" }, { "affiliation": [], "family": "Ibrahim", "given": "Reham R.", "sequence": "additional" }, { "affiliation": [], "family": "Mahgoub", "given": "Shahenda", "sequence": "additional" }, { "affiliation": [], "family": "Abdel-Aziz", "given": "Mohamed S.", "sequence": "additional" }, { "affiliation": [], "family": "Said", "given": "Ahmed M.", "sequence": "additional" }, { "affiliation": [], "family": "Huang", "given": "Hui-Chi", "sequence": "additional" }, { "affiliation": [], "family": "Chen", "given": "Lo-Yun", "sequence": "additional" }, { "ORCID": "https://orcid.org/0000-0001-7220-6356", "affiliation": [], "authenticated-orcid": true, "family": "Lai", "given": "Kuei-Hung", "sequence": "additional" }, { "affiliation": [], "family": "Hashad", "given": "Nashwa", "sequence": "additional" }, { "ORCID": "https://orcid.org/0000-0002-8754-0442", "affiliation": [], "authenticated-orcid": true, "family": "Mady", "given": "Mohamed S.", "sequence": "additional" } ], "container-title": "PLOS ONE", "container-title-short": "PLoS ONE", "content-domain": { "crossmark-restriction": false, "domain": [ "www.plosone.org" ] }, "created": { "date-parts": [ [ 2025, 1, 24 ] ], "date-time": "2025-01-24T18:58:12Z", "timestamp": 1737745092000 }, "deposited": { "date-parts": [ [ 2025, 1, 24 ] ], "date-time": "2025-01-24T18:58:49Z", "timestamp": 1737745129000 }, "editor": [ { "affiliation": [], "family": "Le Ba", "given": "Vinh", "sequence": "first" } ], "funder": [ { "DOI": "10.13039/100020595", "award": [ "(MOST 111-2321-B-255-001), MOST 111-2320-B-038-040-MY3)" ], "doi-asserted-by": "crossref", "id": [ { "asserted-by": "crossref", "id": "10.13039/100020595", "id-type": "DOI" } ], "name": "National Science and Technology Council of Taiwan" }, { "DOI": "10.13039/501100004391", "award": [ "CMU110-MF-52" ], "doi-asserted-by": "publisher", "id": [ { "asserted-by": "publisher", "id": "10.13039/501100004391", "id-type": "DOI" } ], "name": "China Medical University Hospital" } ], "indexed": { "date-parts": [ [ 2025, 1, 25 ] ], "date-time": "2025-01-25T05:26:53Z", "timestamp": 1737782813440, "version": "3.33.0" }, "is-referenced-by-count": 0, "issue": "1", "issued": { "date-parts": [ [ 2025, 1, 24 ] ] }, "journal-issue": { "issue": "1", "published-online": { "date-parts": [ [ 2025, 1, 24 ] ] } }, "language": "en", "license": [ { "URL": "http://creativecommons.org/licenses/by/4.0/", "content-version": "vor", "delay-in-days": 0, "start": { "date-parts": [ [ 2025, 1, 24 ] ], "date-time": "2025-01-24T00:00:00Z", "timestamp": 1737676800000 } } ], "link": [ { "URL": "https://dx.plos.org/10.1371/journal.pone.0313616", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking" } ], "member": "340", "original-title": [], "page": "e0313616", "prefix": "10.1371", "published": { "date-parts": [ [ 2025, 1, 24 ] ] }, "published-online": { "date-parts": [ [ 2025, 1, 24 ] ] }, "publisher": "Public Library of Science (PLoS)", "reference": [ { "DOI": "10.1038/s41586-020-2012-7", "article-title": "A pneumonia outbreak associated with a new coronavirus of probable bat origin", "author": "P Zhou", "doi-asserted-by": "crossref", "first-page": "270", "issue": "7798", "journal-title": "Nature", "key": "pone.0313616.ref001", "volume": "579", "year": "2020" }, { "DOI": "10.1161/HYPERTENSIONAHA.120.15595", "article-title": "ACE2 (Angiotensin-Converting Enzyme 2) in Cardiopulmonary Diseases: Ramifications for the Control of SARS-CoV-2.", "author": "RK Sharma", "doi-asserted-by": "crossref", "first-page": "651", "issue": "3", "journal-title": "Hypertension", "key": "pone.0313616.ref002", "volume": "76", "year": "2020" }, { "DOI": "10.7150/thno.48076", "article-title": "SARS-CoV-2 pandemic and research gaps: Understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapy", "author": "PK Datta", "doi-asserted-by": "crossref", "first-page": "7448", "issue": "16", "journal-title": "Theranostics", "key": "pone.0313616.ref003", "volume": "10", "year": "2020" }, { "DOI": "10.1038/nature00786", "article-title": "Angiotensin-converting enzyme 2 is an essential regulator of heart function", "author": "MA Crackower", "doi-asserted-by": "crossref", "first-page": "822", "issue": "6891", "journal-title": "Nature", "key": "pone.0313616.ref004", "volume": "417", "year": "2002" }, { "DOI": "10.1152/physrev.00023.2016", "article-title": "The ACE2/Angiotensin-(1–7)/MAS Axis of the Renin-Angiotensin System: Focus on Angiotensin-(1–7).", "author": "RAS Santos", "doi-asserted-by": "crossref", "first-page": "505", "issue": "1", "journal-title": "Physiological Reviews", "key": "pone.0313616.ref005", "volume": "98", "year": "2017" }, { "DOI": "10.1161/01.HYP.0000237862.94083.45", "article-title": "Enalapril Attenuates Downregulation of Angiotensin-Converting Enzyme 2 in the Late Phase of Ventricular Dysfunction in Myocardial Infarcted Rat", "author": "MP Ocaranza", "doi-asserted-by": "crossref", "first-page": "572", "issue": "4", "journal-title": "Hypertension", "key": "pone.0313616.ref006", "volume": "48", "year": "2006" }, { "DOI": "10.1016/j.mehy.2020.109782", "article-title": "Purposing Saikosaponins for the treatment of COVID-19.", "author": "EI Bahbah", "doi-asserted-by": "crossref", "first-page": "109782", "journal-title": "Med Hypotheses.", "key": "pone.0313616.ref007", "volume": "140", "year": "2020" }, { "DOI": "10.1038/s41586-020-2180-5", "article-title": "Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor", "author": "J Lan", "doi-asserted-by": "crossref", "first-page": "215", "issue": "7807", "journal-title": "Nature", "key": "pone.0313616.ref008", "volume": "581", "year": "2020" }, { "DOI": "10.1002/emmm.201000080", "article-title": "Angiotensin II revisited: new roles in inflammation, immunology and aging", "author": "A Benigni", "doi-asserted-by": "crossref", "first-page": "247", "issue": "7", "journal-title": "EMBO Mol Med", "key": "pone.0313616.ref009", "volume": "2", "year": "2010" }, { "DOI": "10.1038/sj.jhh.1002101", "article-title": "Angiotensin II and inflammation: the effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockade", "author": "P Dandona", "doi-asserted-by": "crossref", "first-page": "20", "issue": "1", "journal-title": "J Hum Hypertens", "key": "pone.0313616.ref010", "volume": "21", "year": "2007" }, { "DOI": "10.1016/j.immuni.2020.04.003", "article-title": "COVID-19: A New Virus, but a Familiar Receptor and Cytokine Release Syndrome", "author": "T Hirano", "doi-asserted-by": "crossref", "first-page": "731", "issue": "1097–4180 (Electronic)", "journal-title": "Immunity", "key": "pone.0313616.ref011", "volume": "52", "year": "2020" }, { "DOI": "10.3389/fneur.2020.573095", "article-title": "The Spatial and Cell-Type Distribution of SARS-CoV-2 Receptor ACE2 in the Human and Mouse Brains.", "author": "R Chen", "doi-asserted-by": "crossref", "journal-title": "Front Neurol.", "key": "pone.0313616.ref012", "volume": "11", "year": "2021" }, { "DOI": "10.1186/s13045-020-00954-7", "article-title": "SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19.", "author": "S Zhang", "doi-asserted-by": "crossref", "first-page": "120", "issue": "1", "journal-title": "J Hematol Oncol", "key": "pone.0313616.ref013", "volume": "13", "year": "2020" }, { "DOI": "10.1021/acsomega.2c06451", "article-title": "Attenuation of Lipopolysaccharide-Induced Inflammatory Responses through Inhibition of the NF-κB Pathway and the Increased NRF2 Level by a Flavonol-Enriched n-Butanol Fraction from Uvaria alba.", "author": "KIR Notarte", "doi-asserted-by": "crossref", "first-page": "5377", "issue": "6", "journal-title": "ACS Omega.", "key": "pone.0313616.ref014", "volume": "8", "year": "2023" }, { "DOI": "10.1186/s12950-021-00268-6", "article-title": "Anti-inflammatory potential of Quercetin in COVID-19 treatment", "author": "A Saeedi-Boroujeni", "doi-asserted-by": "crossref", "first-page": "3", "issue": "1", "journal-title": "J Inflamm (Lond).", "key": "pone.0313616.ref015", "volume": "18", "year": "2021" }, { "DOI": "10.1016/j.bbrc.2020.05.028", "article-title": "Interaction of the spike protein RBD from SARS-CoV-2 with ACE2: Similarity with SARS-CoV, hot-spot analysis and effect of the receptor polymorphism", "author": "H Othman", "doi-asserted-by": "crossref", "first-page": "702", "issue": "3", "journal-title": "Biochem Biophys Res Commun", "key": "pone.0313616.ref016", "volume": "527", "year": "2020" }, { "DOI": "10.1038/s41423-020-0374-2", "article-title": "Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein", "author": "S Xia", "doi-asserted-by": "crossref", "first-page": "765", "issue": "7", "journal-title": "Cell Mol Immunol", "key": "pone.0313616.ref017", "volume": "17", "year": "2020" }, { "DOI": "10.1074/jbc.M408782200", "article-title": "Crystal structure of severe acute respiratory syndrome coronavirus spike protein fusion core", "author": "Y Xu", "doi-asserted-by": "crossref", "first-page": "49414", "issue": "47", "journal-title": "J Biol Chem", "key": "pone.0313616.ref018", "volume": "279", "year": "2004" }, { "article-title": "Computational Drug Repurposing Studies on the ACE2-Spike (RBD) Interface of SARS-CoV-22020.", "author": "V Jani", "key": "pone.0313616.ref019" }, { "DOI": "10.1111/acel.13168", "article-title": "Individual variation of the SARS-CoV-2 receptor ACE2 gene expression and regulation", "author": "J Chen", "doi-asserted-by": "crossref", "first-page": "e13168", "issue": "7", "journal-title": "Aging Cell", "key": "pone.0313616.ref020", "volume": "19", "year": "2020" }, { "DOI": "10.1002/ptr.6700", "article-title": "Natural products and their derivatives against coronavirus: A review of the non‐clinical and pre‐clinical data.", "author": "MT Islam", "doi-asserted-by": "crossref", "first-page": "2471", "issue": "10", "journal-title": "PHYTOTHER RES", "key": "pone.0313616.ref021", "volume": "34", "year": "2020" }, { "DOI": "10.1172/JCI137244", "article-title": "Clinical and immunological features of severe and moderate coronavirus disease 2019", "author": "G Chen", "doi-asserted-by": "crossref", "first-page": "5", "journal-title": "J Clin Invest", "key": "pone.0313616.ref022", "volume": "130", "year": "2020" }, { "DOI": "10.1172/JCI137647", "article-title": "SARS-CoV-2: a storm is raging", "author": "SF Pedersen", "doi-asserted-by": "crossref", "issue": "5", "journal-title": "J Clin Invest", "key": "pone.0313616.ref023", "volume": "130", "year": "2020" }, { "DOI": "10.1016/j.immuni.2020.06.017", "article-title": "Cytokine Storms: Understanding COVID-19", "author": "N Mangalmurti", "doi-asserted-by": "crossref", "first-page": "19", "issue": "1", "journal-title": "Immunity", "key": "pone.0313616.ref024", "volume": "53", "year": "2020" }, { "DOI": "10.3389/fimmu.2020.576745", "article-title": "ACE2/ADAM17/TMPRSS2 Interplay May Be the Main Risk Factor for COVID-19.", "author": "D Zipeto", "doi-asserted-by": "crossref", "journal-title": "Front Immunol.", "key": "pone.0313616.ref025", "volume": "11", "year": "2020" }, { "DOI": "10.1038/s41467-020-18319-6", "article-title": "Molecular interaction and inhibition of SARS-CoV-2 binding to the ACE2 receptor", "author": "J Yang", "doi-asserted-by": "crossref", "first-page": "4541", "issue": "1", "journal-title": "Nature Communications", "key": "pone.0313616.ref026", "volume": "11", "year": "2020" }, { "DOI": "10.2174/1386207325666210917113207", "article-title": "Polyphenolic Natural Products Active In Silico Against SARS-CoV-2 Spike Receptor Binding Domains and Non-structural Proteins—A Review", "author": "M Quimque Tristan", "doi-asserted-by": "crossref", "first-page": "459", "issue": "3", "journal-title": "Combinatorial Chemistry & High Throughput Screening.", "key": "pone.0313616.ref027", "volume": "26", "year": "2023" }, { "article-title": "Virtual Combinatorial Library Screening of Quinadoline B Derivatives against SARS-CoV-2 RNA-Dependent RNA Polymerase.", "author": "S Brogi", "issue": "1", "journal-title": "Computation [Internet].", "key": "pone.0313616.ref028", "volume": "10", "year": "2022" }, { "article-title": "Phytochemistry and Pharmacology of Callistemon viminali (Myrtaceae): A Review.", "author": "K Ahmad", "first-page": "166", "issue": "3", "journal-title": "Nat Prod J.", "key": "pone.0313616.ref029", "volume": "7", "year": "2017" }, { "article-title": "Studying of antibacterial effect for leaves extract of Callistemon viminalis in vitro and vivo (urinary system) for rabbits.", "author": "J. Abd", "first-page": "246", "journal-title": "JOK", "key": "pone.0313616.ref030", "volume": "8", "year": "2012" }, { "DOI": "10.1016/j.apjtm.2017.03.015", "article-title": "Medicinal and biological values of Callistemon viminalis extracts: History, current situation and prospects", "author": "MZM Salem", "doi-asserted-by": "crossref", "first-page": "229", "issue": "3", "journal-title": "Asian Pac J Trop Med", "key": "pone.0313616.ref031", "volume": "10", "year": "2017" }, { "DOI": "10.2174/1389201020666191107110341", "article-title": "Phytochemical and Cytotoxicity Studies of Callistemon viminalis Leaves Extract Growing in Egypt", "author": "AH Ahmed", "doi-asserted-by": "crossref", "first-page": "219", "issue": "3", "journal-title": "Curr Pharm Biotechnol.", "key": "pone.0313616.ref032", "volume": "21", "year": "2020" }, { "DOI": "10.3390/molecules18032528", "article-title": "Identification of Alternaria alternata mycotoxins by LC-SPE-NMR and their cytotoxic effects to soybean (Glycine max) cell suspension culture.", "author": "GD De Souza", "doi-asserted-by": "crossref", "first-page": "2528", "issue": "3", "journal-title": "Molecules", "key": "pone.0313616.ref033", "volume": "18", "year": "2013" }, { "DOI": "10.1080/14786419.2012.718771", "article-title": "One new pyrroline compound from Callistemon viminalis (Sol. Ex Gaertner) G.Don Ex Loudon", "author": "AA Gohar", "doi-asserted-by": "crossref", "first-page": "1179", "issue": "13", "journal-title": "Nat Prod Res", "key": "pone.0313616.ref034", "volume": "27", "year": "2013" }, { "DOI": "10.3390/molecules26092481", "article-title": "Polyphenolic Profile of Callistemon viminalis Aerial Parts: Antioxidant, Anticancer and In Silico 5-LOX Inhibitory Evaluations.", "author": "S Mahgoub", "doi-asserted-by": "crossref", "issue": "9", "journal-title": "Molecules.", "key": "pone.0313616.ref035", "volume": "26", "year": "2021" }, { "DOI": "10.1016/S1995-7645(13)60139-X", "article-title": "Evaluation of extracts and essential oil from Callistemon viminalis leaves: antibacterial and antioxidant activities, total phenolic and flavonoid contents", "author": "MZ Salem", "doi-asserted-by": "crossref", "first-page": "785", "issue": "10", "journal-title": "Asian Pac J Trop Med", "key": "pone.0313616.ref036", "volume": "6", "year": "2013" }, { "DOI": "10.1016/j.fitote.2016.10.007", "article-title": "Callviminols A-E, new terpenoid-conjugated phloroglucinols from the leaves of Callistemon viminalis", "author": "HX Liu", "doi-asserted-by": "crossref", "first-page": "142", "journal-title": "Fitoterapia", "key": "pone.0313616.ref037", "volume": "115", "year": "2016" }, { "DOI": "10.1021/acs.jnatprod.9b00064", "article-title": "Callistemonols A and B, Potent Antimicrobial Acylphloroglucinol Derivatives with Unusual Carbon Skeletons from Callistemon viminalis", "author": "JW Wu", "doi-asserted-by": "crossref", "first-page": "1917", "issue": "7", "journal-title": "J Nat Prod", "key": "pone.0313616.ref038", "volume": "82", "year": "2019" }, { "DOI": "10.1016/j.phytol.2017.04.014", "article-title": "Acylphloroglucinols from the fruits of Callistemon viminalis.", "author": "L Wu", "doi-asserted-by": "crossref", "first-page": "61", "journal-title": "Phytochem Lett.", "key": "pone.0313616.ref039", "volume": "20", "year": "2017" }, { "article-title": "Evaluating anti-oxidant potential of Callistemon viminalis leaves extracts and their compounds in STAT 3 pathway in liver cancer", "author": "K. Ahmad", "first-page": "mdx652. 013", "issue": "suppl_10", "journal-title": "Annals of Oncology", "key": "pone.0313616.ref040", "volume": "28", "year": "2017" }, { "article-title": "Evaluation of anti-breast cancer, anti-angiogenic and antioxidant properties of selected medicinal plants.", "author": "SS Kamble", "first-page": "13", "journal-title": "EuJIM", "key": "pone.0313616.ref041", "volume": "25", "year": "2019" }, { "DOI": "10.14218/JERP.2016.00036", "article-title": "Pleiotropic Chemodiversity in Extracts and Essential Oil of Melaleuca viminalis and Melaleuca armillaris of Myrtaceae Family.", "author": "M Bhagat", "doi-asserted-by": "crossref", "first-page": "113", "issue": "4", "journal-title": "JERP", "key": "pone.0313616.ref042", "volume": "2", "year": "2017" }, { "article-title": "A report on antioxidant and antibacterial properties of Callistemon viminalis leaf", "author": "N Hasan", "first-page": "36", "issue": "7", "journal-title": "International Journal of Pharmaceutical Science and Research", "key": "pone.0313616.ref043", "volume": "1", "year": "2016" }, { "article-title": "Evaluation of antioxidant and antibacterial activities of methanolic leaf extract of Calistemon viminalis.", "author": "U Tiwari", "first-page": "1", "journal-title": "JPSBM", "key": "pone.0313616.ref044", "volume": "2", "year": "2014" }, { "article-title": "In-vitro evaluation of the antidiabetic activity of bottle brush plants.", "author": "MI Abdelhady", "first-page": "134", "issue": "4", "journal-title": "RRBS", "key": "pone.0313616.ref045", "volume": "9", "year": "2014" }, { "article-title": "Comparative Analgesic Activity of Selected Medicinal Plants from Pakistan.", "author": "H Shareef", "first-page": "57", "issue": "3", "journal-title": "Proceedings of the Pakistan Academy of Sciences: B Life and Environmental Sciences.", "key": "pone.0313616.ref046", "volume": "56", "year": "2019" }, { "DOI": "10.2174/187220810790069523", "article-title": "The use of beneficial microbial endophytes for plant biomass and stress tolerance improvement.", "author": "C Mei", "doi-asserted-by": "crossref", "first-page": "81", "issue": "1", "journal-title": "Recent Pat Biotechnol.", "key": "pone.0313616.ref047", "volume": "4", "year": "2010" }, { "DOI": "10.1016/B978-0-12-819541-3.00004-9", "author": "TEE dela Cruz", "doi-asserted-by": "crossref", "first-page": "51", "key": "pone.0313616.ref048", "volume-title": "Biodiversity and Biomedicine", "year": "2020" }, { "DOI": "10.6064/2012/635431", "article-title": "Stress Response and Pathogenicity of the Necrotrophic Fungal Pathogen Alternaria alternata.", "author": "KR Chung", "doi-asserted-by": "crossref", "first-page": "635431", "journal-title": "Scientifica", "key": "pone.0313616.ref049", "volume": "2012", "year": "2012" }, { "article-title": "Alternaria metabolites—chemical and biological data", "author": "N Montemurro", "journal-title": "Alternaria: biology, plant diseases, and metabolites/editors, J Chelkowski and A Visconti.", "key": "pone.0313616.ref050", "year": "1992" }, { "article-title": "Alternaria species: endophytic fungi as alternative sources of bioactive compounds", "author": "D Eram", "first-page": "40", "journal-title": "Italian Journal of Mycology", "key": "pone.0313616.ref051", "volume": "47", "year": "2018" }, { "DOI": "10.3390/molecules18055891", "article-title": "Metabolites from Alternaria fungi and their bioactivities.", "author": "J Lou", "doi-asserted-by": "crossref", "first-page": "5891", "issue": "5", "journal-title": "Molecules", "key": "pone.0313616.ref052", "volume": "18", "year": "2013" }, { "DOI": "10.3390/molecules25020395", "article-title": "Naturally Occurring Isocoumarins Derivatives from Endophytic Fungi: Sources, Isolation, Structural Characterization, Biosynthesis, and Biological Activities.", "author": "AO Noor", "doi-asserted-by": "crossref", "first-page": "395", "issue": "2", "journal-title": "Molecules", "key": "pone.0313616.ref053", "volume": "25", "year": "2020" }, { "DOI": "10.1016/j.ijheh.2023.114224", "article-title": "The dominance of co-circulating SARS-CoV-2 variants in wastewater", "author": "JD Pilapil", "doi-asserted-by": "crossref", "first-page": "114224", "journal-title": "International Journal of Hygiene and Environmental Health", "key": "pone.0313616.ref054", "volume": "253", "year": "2023" }, { "DOI": "10.3390/molecules27134305", "article-title": "Microbial Natural Products with Antiviral Activities, Including Anti-SARS-CoV-2: A Review", "author": "AA-O Frediansyah", "doi-asserted-by": "crossref", "first-page": "4305", "issue": "1420–3049 (Electronic)", "journal-title": "Molecules", "key": "pone.0313616.ref055", "volume": "7", "year": "2022" }, { "DOI": "10.3390/molecules25245888", "article-title": "Can Natural Polyphenols Help in Reducing Cytokine Storm in COVID-19 Patients?", "author": "G Giovinazzo", "doi-asserted-by": "crossref", "first-page": "5888", "issue": "24", "journal-title": "Molecules", "key": "pone.0313616.ref056", "volume": "25", "year": "2020" }, { "DOI": "10.1002/vjch.202100099", "article-title": "Review: Bioactive metabolites and host-specific toxins from endophytic Fungi, Alternaria alternate", "author": "N Hashad", "doi-asserted-by": "crossref", "first-page": "733", "issue": "6", "journal-title": "Vietnam Journal of Chemistry", "key": "pone.0313616.ref057", "volume": "59", "year": "2021" }, { "DOI": "10.1134/S0003683815050099", "article-title": "Alternariol derivatives from Alternaria alternata, an endophytic fungus residing in red sea soft coral, inhibit HCV NS3/4A protease", "author": "UW Hawas", "doi-asserted-by": "crossref", "first-page": "579", "issue": "5", "journal-title": "Applied Biochemistry and Microbiology", "key": "pone.0313616.ref058", "volume": "51", "year": "2015" }, { "article-title": "Taxonomy of endophytic fungi of aerial plant tissues", "author": "O. Petrini", "journal-title": "Microbiology of the phyllosphere/edited by NJ Fokkema and J van den Heuvel", "key": "pone.0313616.ref059", "year": "1986" }, { "DOI": "10.1016/S0953-7562(09)80215-3", "article-title": "Endophytes from herbaceous plants and shrubs: effectiveness of surface sterilization methods", "author": "B Schulz", "doi-asserted-by": "crossref", "first-page": "1447", "issue": "12", "journal-title": "Mycol Res", "key": "pone.0313616.ref060", "volume": "97", "year": "1993" }, { "author": "MA Innis", "key": "pone.0313616.ref061", "volume-title": "PCR protocols: a guide to methods and applications", "year": "2012" }, { "article-title": "Antibacterial activity of endophytic fungi extracts from the medicinal plant Kigelia africana.", "author": "A-m Idris", "first-page": "1", "issue": "1", "journal-title": "Egypt Acad J Biol Sci", "key": "pone.0313616.ref062", "volume": "5", "year": "2013" }, { "DOI": "10.3389/fphar.2022.1006062", "article-title": "Anti-prostate cancer metabolites from the soil-derived Aspergillus neoniveus", "author": "M Fayek", "doi-asserted-by": "crossref", "journal-title": "Front Pharmacol", "key": "pone.0313616.ref063", "volume": "13", "year": "2022" }, { "DOI": "10.1186/s13568-023-01612-0", "article-title": "Bioactive metabolites identified from Aspergillus terreus derived from soil.", "author": "M Fayek", "doi-asserted-by": "crossref", "first-page": "107", "journal-title": "AMB Express, 13(1), 107.", "key": "pone.0313616.ref064", "volume": "13", "year": "2023" }, { "DOI": "10.1002/jcc.21334", "article-title": "AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading", "author": "O Trott", "doi-asserted-by": "crossref", "first-page": "455", "issue": "2", "journal-title": "Journal of Computational Chemistry", "key": "pone.0313616.ref065", "volume": "31", "year": "2010" }, { "DOI": "10.1016/j.softx.2015.06.001", "article-title": "GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers.", "author": "MJ Abraham", "doi-asserted-by": "crossref", "first-page": "19", "journal-title": "SoftwareX", "key": "pone.0313616.ref066", "volume": "1–2", "year": "2015" }, { "DOI": "10.1021/ci500020m", "article-title": "g_mmpbsa—A GROMACS Tool for High-Throughput MM-PBSA Calculations", "author": "R Kumari", "doi-asserted-by": "crossref", "first-page": "1951", "issue": "7", "journal-title": "Journal of Chemical Information and Modeling", "key": "pone.0313616.ref067", "volume": "54", "year": "2014" }, { "article-title": "The PreADME Approach: Web-based program for rapid prediction of physico-chemical, drug absorption and drug-like properties.", "author": "S Lee", "first-page": "418", "journal-title": "euro QSAR 2002—Designing Drugs and Crop Protectants: Processes Problems and Solutions.", "key": "pone.0313616.ref068", "volume": "2002" }, { "DOI": "10.1126/science.abb2762", "article-title": "Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2", "author": "R Yan", "doi-asserted-by": "crossref", "first-page": "1444", "issue": "6485", "journal-title": "Science", "key": "pone.0313616.ref069", "volume": "367", "year": "2020" }, { "DOI": "10.1016/j.cell.2020.02.052", "article-title": "SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor", "author": "M Hoffmann", "doi-asserted-by": "crossref", "first-page": "271", "issue": "2", "journal-title": "Cell", "key": "pone.0313616.ref070", "volume": "181", "year": "2020" }, { "article-title": "Quercetin and Vitamin C: An Experimental, Synergistic Therapy for the Prevention and Treatment of SARS-CoV-2 Related Disease (COVID-19).", "author": "RML Colunga Biancatelli", "key": "pone.0313616.ref071", "volume": "11", "year": "2020" }, { "DOI": "10.1016/j.jpha.2021.09.009", "article-title": "Antiviral, immunomodulatory, and anticoagulant effects of quercetin and its derivatives: Potential role in prevention and management of COVID-19", "author": "SH Manjunath", "doi-asserted-by": "crossref", "first-page": "29", "issue": "1", "journal-title": "Journal of Pharmaceutical Analysis", "key": "pone.0313616.ref072", "volume": "12", "year": "2022" }, { "DOI": "10.1016/0022-1759(83)90303-4", "article-title": "Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays", "author": "T. Mosmann", "doi-asserted-by": "crossref", "first-page": "55", "issue": "1–2", "journal-title": "Journal of immunological methods", "key": "pone.0313616.ref073", "volume": "65", "year": "1983" }, { "DOI": "10.1016/0003-2697(76)90527-3", "article-title": "A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding", "author": "MM Bradford", "doi-asserted-by": "crossref", "first-page": "248", "journal-title": "Anal Biochem", "key": "pone.0313616.ref074", "volume": "72", "year": "1976" }, { "article-title": "Improving Influenza HA-Vlps Production in Insect High Five Cells via Adaptive Laboratory Evolution.", "author": "R Correia", "issue": "4", "journal-title": "Vaccines [Internet].", "key": "pone.0313616.ref075", "volume": "8", "year": "2020" }, { "DOI": "10.3389/fnins.2019.00049", "article-title": "Targeting TNFR2 as a novel therapeutic strategy for Alzheimer’s disease.", "author": "N Ortí-Casañ", "doi-asserted-by": "crossref", "first-page": "49", "journal-title": "Front Neurosci.", "key": "pone.0313616.ref076", "volume": "13", "year": "2019" }, { "DOI": "10.1016/j.molmed.2017.09.007", "article-title": "TNFR2: A Novel Target for Cancer Immunotherapy", "author": "ES Vanamee", "doi-asserted-by": "crossref", "first-page": "1037", "issue": "11", "journal-title": "Trends Mol Med", "key": "pone.0313616.ref077", "volume": "23", "year": "2017" }, { "DOI": "10.1016/j.bioorg.2022.106092", "article-title": "Novel hit of DPP-4Is as promising antihyperglycemic agents with dual antioxidant/anti-inflammatory effects for type 2 diabetes with/without COVID-19", "author": "S Mahgoub", "doi-asserted-by": "crossref", "first-page": "106092", "journal-title": "Bioorganic Chemistry", "key": "pone.0313616.ref078", "volume": "128", "year": "2022" }, { "author": "A. Hassan", "key": "pone.0313616.ref079", "volume-title": "Novel natural products from endophytic fungi of Egyptian medicinal plants-chemical and biological characterization [Dissertation].", "year": "2007" }, { "DOI": "10.1016/j.bmc.2007.12.044", "article-title": "1-deoxyrubralactone, a novel specific inhibitor of families X and Y of eukaryotic DNA polymerases from a fungal strain derived from sea algae", "author": "M Naganuma", "doi-asserted-by": "crossref", "first-page": "2939", "issue": "6", "journal-title": "Bioorg Med Chem", "key": "pone.0313616.ref080", "volume": "16", "year": "2008" }, { "DOI": "10.1016/j.cell.2020.03.045", "article-title": "Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2", "author": "Q Wang", "doi-asserted-by": "crossref", "first-page": "894", "issue": "4", "journal-title": "Cell", "key": "pone.0313616.ref081", "volume": "181", "year": "2020" }, { "DOI": "10.1186/s12906-021-03290-6", "article-title": "Antidiarrheal, antimicrobial and antioxidant potentials of methanol extract of Colocasia gigantea Hook. f. leaves: evidenced from in vivo and in vitro studies along with computer-aided approaches", "author": "S Alam", "doi-asserted-by": "crossref", "first-page": "119", "issue": "1", "journal-title": "BMC Complementary Medicine and Therapies", "key": "pone.0313616.ref082", "volume": "21", "year": "2021" }, { "DOI": "10.3390/plants9060770", "article-title": "Geranium and lemon essential oils and their active compounds downregulate angiotensin-converting enzyme 2 (ACE2), a SARS-CoV-2 spike receptor-binding domain, in epithelial cells.", "author": "KJ Senthil Kumar", "doi-asserted-by": "crossref", "first-page": "770", "issue": "6", "journal-title": "Plants", "key": "pone.0313616.ref083", "volume": "9", "year": "2020" }, { "DOI": "10.1016/j.lfs.2020.118056", "article-title": "Structural features of coronavirus SARS-CoV-2 spike protein: Targets for vaccination", "author": "A Sternberg", "doi-asserted-by": "crossref", "first-page": "118056", "journal-title": "Life Sciences", "key": "pone.0313616.ref084", "volume": "257", "year": "2020" }, { "DOI": "10.1007/s00408-020-00408-4", "article-title": "ACE2: The Major Cell Entry Receptor for SARS-CoV-2", "author": "F Scialo", "doi-asserted-by": "crossref", "first-page": "867", "issue": "1432–1750 (Electronic)", "journal-title": "Lung", "key": "pone.0313616.ref085", "volume": "198", "year": "2020" }, { "DOI": "10.3390/molecules25173980", "article-title": "Natural Flavonoids as Potential Angiotensin-Converting Enzyme 2 Inhibitors for Anti-SARS-CoV-2.", "author": "M Muchtaridi", "doi-asserted-by": "crossref", "issue": "17", "journal-title": "Molecules", "key": "pone.0313616.ref086", "volume": "25", "year": "2020" }, { "DOI": "10.1038/s41401-020-0485-4", "article-title": "Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19.", "author": "Y Huang", "doi-asserted-by": "crossref", "first-page": "1141", "issue": "9", "journal-title": "Acta Pharmacologica Sinica.", "key": "pone.0313616.ref087", "volume": "41", "year": "2020" }, { "DOI": "10.1038/s41586-020-2179-y", "article-title": "Structural basis of receptor recognition by SARS-CoV-2", "author": "J Shang", "doi-asserted-by": "crossref", "first-page": "221", "issue": "7807", "journal-title": "Nature", "key": "pone.0313616.ref088", "volume": "581", "year": "2020" }, { "DOI": "10.3389/fphar.2020.01224", "article-title": "SARS-CoV-2 Treatment Approaches: Numerous Options, No Certainty for a Versatile Virus.", "author": "S Iacob", "doi-asserted-by": "crossref", "journal-title": "Front Pharmacol.", "key": "pone.0313616.ref089", "volume": "11", "year": "2020" }, { "DOI": "10.1073/pnas.2106480118", "article-title": "Computational prediction of the effect of amino acid changes on the binding affinity between SARS-CoV-2 spike RBD and human ACE2", "author": "C Chen", "doi-asserted-by": "crossref", "first-page": "e2106480118", "issue": "42", "journal-title": "Proceedings of the National Academy of Sciences", "key": "pone.0313616.ref090", "volume": "118", "year": "2021" }, { "DOI": "10.1055/a-1155-0501", "article-title": "The ACE-2 in COVID-19: Foe or Friend?", "author": "R Dalan", "doi-asserted-by": "crossref", "first-page": "257", "issue": "5", "journal-title": "Horm Metab Res", "key": "pone.0313616.ref091", "volume": "52", "year": "2020" }, { "DOI": "10.1021/acs.jafc.0c05064", "article-title": "Quercetin and Its Metabolites Inhibit Recombinant Human Angiotensin-Converting Enzyme 2 (ACE2) Activity.", "author": "X Liu", "doi-asserted-by": "crossref", "first-page": "13982", "issue": "47", "journal-title": "Journal of Agricultural and Food Chemistry", "key": "pone.0313616.ref092", "volume": "68", "year": "2020" }, { "DOI": "10.3389/fmolb.2021.732256", "article-title": "Microbial Metabolites: The Emerging Hotspot of Antiviral Compounds as Potential Candidates to Avert Viral Pandemic Alike COVID-19.", "author": "T Raihan", "doi-asserted-by": "crossref", "first-page": "732256", "journal-title": "Front Mol Biosci.", "key": "pone.0313616.ref093", "volume": "8", "year": "2021" }, { "DOI": "10.1016/j.compbiomed.2021.104613", "article-title": "In silico investigation on the inhibitory effect of fungal secondary metabolites on RNA dependent RNA polymerase of SARS-CoV-II: A docking and molecular dynamic simulation study", "author": "KS Ebrahimi", "doi-asserted-by": "crossref", "first-page": "104613", "journal-title": "Computers in Biology and Medicine", "key": "pone.0313616.ref094", "volume": "135", "year": "2021" }, { "DOI": "10.1002/rmv.2222", "article-title": "SARS-CoV-2, Covid-19, and the debunking of conspiracy theories", "author": "MS Hakim", "doi-asserted-by": "crossref", "first-page": "e2222", "issue": "6", "journal-title": "Reviews in Medical Virology", "key": "pone.0313616.ref095", "volume": "31", "year": "2021" }, { "DOI": "10.1016/S0140-6736(03)13077-2", "article-title": "Coronavirus as a possible cause of severe acute respiratory syndrome", "author": "JS Peiris", "doi-asserted-by": "crossref", "first-page": "1319", "issue": "0140–6736 (Print)", "journal-title": "Lancet", "key": "pone.0313616.ref096", "volume": "361", "year": "2003" }, { "DOI": "10.1038/s41598-017-01290-6", "article-title": "Tissue distribution of the MERS-coronavirus receptor in bats", "author": "W Widagdo", "doi-asserted-by": "crossref", "first-page": "1193", "issue": "1", "journal-title": "Scientific Reports", "key": "pone.0313616.ref097", "volume": "7", "year": "2017" }, { "DOI": "10.3389/fimmu.2020.01708", "article-title": "Cytokine Storm in COVID-19: The Current Evidence and Treatment Strategies.", "author": "Y Tang", "doi-asserted-by": "crossref", "journal-title": "Front Immunol.", "key": "pone.0313616.ref098", "volume": "11", "year": "2020" }, { "DOI": "10.1007/s40744-021-00342-8", "article-title": "TNF-α Blockers Showed Prophylactic Effects in Preventing COVID-19 in Patients with Rheumatoid Arthritis and Seronegative Spondyloarthropathies: A Case–Control Study.", "author": "M Salesi", "doi-asserted-by": "crossref", "first-page": "1355", "issue": "3", "journal-title": "Rheumatol Ther.", "key": "pone.0313616.ref099", "volume": "8", "year": "2021" }, { "DOI": "10.1007/978-3-030-22094-5_3", "author": "M. Shimizu", "doi-asserted-by": "crossref", "first-page": "31", "key": "pone.0313616.ref100", "volume-title": "Cytokine storm syndrome", "year": "2019" }, { "DOI": "10.1016/S2665-9913(20)30309-X", "article-title": "Accumulating evidence suggests anti-TNF therapy needs to be given trial priority in COVID-19 treatment", "author": "PC Robinson", "doi-asserted-by": "crossref", "first-page": "e653", "issue": "11", "journal-title": "The Lancet Rheumatology", "key": "pone.0313616.ref101", "volume": "2", "year": "2020" }, { "article-title": "Suppression of Proinflammatory Cytokines and Mediators in LPS-Induced RAW 264.7 Macrophages by Stem Extract of Alternanthera sessilis via the Inhibition of the NF-κB Pathway.", "author": "K Muniandy", "first-page": "3430684", "journal-title": "J Immun Res.", "key": "pone.0313616.ref102", "volume": "2018", "year": "2018" }, { "DOI": "10.3390/molecules28186531", "article-title": "Screening of Anti-Inflammatory Activity and Metabolomics Analysis of Endophytic Fungal Extracts; Identification and Characterization of Perylenequinones and Terpenoids from the Interesting Active Alternaria Endophyte.", "author": "R Spina", "doi-asserted-by": "crossref", "first-page": "6531", "issue": "18", "journal-title": "Molecules", "key": "pone.0313616.ref103", "volume": "28", "year": "2023" }, { "DOI": "10.1080/12298093.2020.1756134", "article-title": "Draft genome sequence of Alternaria alternata JS-1623, a fungal endophyte of Abies koreana.", "author": "S-Y Park", "doi-asserted-by": "crossref", "first-page": "240", "issue": "3", "journal-title": "Mycobiology", "key": "pone.0313616.ref104", "volume": "48", "year": "2020" }, { "DOI": "10.3389/fphar.2020.588508", "article-title": "Current prevention of COVID-19: natural products and herbal medicine", "author": "J Huang", "doi-asserted-by": "crossref", "first-page": "588508", "journal-title": "Frontiers in Pharmacology", "key": "pone.0313616.ref105", "volume": "11", "year": "2020" } ], "reference-count": 105, "references-count": 105, "relation": {}, "resource": { "primary": { "URL": "https://dx.plos.org/10.1371/journal.pone.0313616" } }, "score": 1, "short-title": [], "source": "Crossref", "subject": [], "subtitle": [], "title": "Secondary metabolites of Alternaria alternate appraisal of their SARS-CoV-2 inhibitory and anti-inflammatory potentials", "type": "journal-article", "update-policy": "https://doi.org/10.1371/journal.pone.corrections_policy", "volume": "20" }
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit